Cisplatin and its analogues in the treatment of advanced breast cancer
1992
Cisplatin and its analogues in advanced breast cancer
Sample size: 58
publication
Author Information
Author(s): Smith, Talbot
Conclusion
The study provides additional data on the effectiveness of cisplatin and its analogues in treating advanced breast cancer.
Supporting Evidence
- The response evaluation rate was 67%.
- The median response duration was 11 months.
Takeaway
Cisplatin can help some people with advanced breast cancer, and this study shows how well it works.
Want to read the original?
Access the complete publication on the publisher's website